SAGE CLASS ACTION: Sage Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
17 sept. 2024 19h45 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs
SAGE Class Action Alert: Robbins LLP Reminds Stockholders of the Sage Therapeutics, Inc. Class Action
04 sept. 2024 18h25 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Sage Therapeutics, Inc.
29 août 2024 15h37 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs
Sage Therapeutics, Inc.: Company Investigated by the Portnoy Law Firm
28 août 2023 17h53 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sage Therapeutics, Inc....